JP2015036368A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015036368A5 JP2015036368A5 JP2013167198A JP2013167198A JP2015036368A5 JP 2015036368 A5 JP2015036368 A5 JP 2015036368A5 JP 2013167198 A JP2013167198 A JP 2013167198A JP 2013167198 A JP2013167198 A JP 2013167198A JP 2015036368 A5 JP2015036368 A5 JP 2015036368A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- estrogen
- dodecenyl
- testosterone secretion
- dodecenyl acetate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 claims description 24
- 229960003604 Testosterone Drugs 0.000 claims description 12
- -1 dodecenyl acetate Chemical compound 0.000 claims description 12
- 239000000262 estrogen Substances 0.000 claims description 12
- 230000028327 secretion Effects 0.000 claims description 11
- 230000002708 enhancing Effects 0.000 claims description 9
- 239000004480 active ingredient Substances 0.000 claims description 4
- 239000003205 fragrance Substances 0.000 claims description 3
- 239000005445 natural product Substances 0.000 claims description 3
- 229930014626 natural products Natural products 0.000 claims description 3
- 210000004556 Brain Anatomy 0.000 claims description 2
- 210000000196 Olfactory Nerve Anatomy 0.000 claims description 2
- YWWVWXASSLXJHU-AATRIKPKSA-M (E)-tetradec-9-enoate Chemical compound CCCC\C=C\CCCCCCCC([O-])=O YWWVWXASSLXJHU-AATRIKPKSA-M 0.000 description 1
- YWWVWXASSLXJHU-WAYWQWQTSA-M myristoleate Chemical compound CCCC\C=C/CCCCCCCC([O-])=O YWWVWXASSLXJHU-WAYWQWQTSA-M 0.000 description 1
- 230000003248 secreting Effects 0.000 description 1
Description
即ち、請求項１の発明は、合成されたドデセニルアセテート又は天然物から単離、精製されたドデセニルアセテートを有効成分として含有するエストロジェン及びテストステロン分泌増進用組成物である。
請求項２の発明は、請求項１又は２に記載のエストロジェン及びテストステロン分泌増進用組成物において、前記合成されたドデセニルアセテート又は天然物から単離、精製されたドデセニルアセテートは、Ｚ−7−ドデセニル(dodecen-1-yl)-アセテート(acetate)又はＥ−7−ドデセニル(dodecen-1-yl)-アセテート(acetate)などの類似異性体を含むものであることを特徴する。
請求項３の発明は、請求項１又は２に記載のエストロジェン及びテストステロン分泌増進用組成物において、前記組成物の投与手段が嗅覚神経を介して脳に伝達されるように投与することを特徴とする。
請求項４の発明は、合成されたドデセニルアセテート又は天然物から単離、精製されたドデセニルアセテートを有効成分として含有することを特徴するエストロジェン及びテストステロン分泌芳香用組成物である。
請求項５の発明は、請求項１〜４のいずれかのエストロジェン及びテストステロン分泌増進用組成物を含有するエストロジェン及びテストステロン分泌増進用芳香用具である。
That is, the invention of claim 1 is a composition for enhancing estrogen and testosterone secretion containing dodecenyl acetate synthesized or isolated from purified natural dodecenyl acetate as an active ingredient.
The invention of claim 2 is the composition for enhancing estrogen and testosterone secretion according to claim 1 or 2, wherein the synthesized dodecenyl acetate or the purified dodecenyl acetate is isolated from a natural product. , Z-7-dodecen-1-yl-acetate or E-7-dodecen-1-yl-acetate.
The invention of claim 3 is the composition for enhancing estrogen and testosterone secretion according to claim 1 or 2, wherein the administration means of the composition is administered so as to be transmitted to the brain via the olfactory nerve. To do.
The invention of claim 4 is a composition for estrogen and testosterone secreting fragrance characterized by containing dodecenyl acetate synthesized or isolated from purified natural dodecenyl acetate as an active ingredient. .
The invention of claim 5 is any of estrogen and estrogen and testosterone secretion for enhancing aroma tool containing testosterone secretion enhancing composition of claims 1-4.
Claims (5)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013167198A JP5923469B2 (en) | 2013-08-10 | 2013-08-10 | A composition for enhancing estrogen and testosterone secretion, a fragrance composition thereof, and a fragrance device thereof. |
| PCT/JP2014/068676 WO2015022831A1 (en) | 2013-08-10 | 2014-07-14 | Composition for promoting estrogen and testosterone secretion, aromatic composition thereof, and aromatic tool thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013167198A JP5923469B2 (en) | 2013-08-10 | 2013-08-10 | A composition for enhancing estrogen and testosterone secretion, a fragrance composition thereof, and a fragrance device thereof. |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015036368A JP2015036368A (en) | 2015-02-23 |
| JP2015036368A5 true JP2015036368A5 (en) | 2015-06-25 |
| JP5923469B2 JP5923469B2 (en) | 2016-05-24 |
Family
ID=52468221
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013167198A Active JP5923469B2 (en) | 2013-08-10 | 2013-08-10 | A composition for enhancing estrogen and testosterone secretion, a fragrance composition thereof, and a fragrance device thereof. |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JP5923469B2 (en) |
| WO (1) | WO2015022831A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2020007261A (en) * | 2018-07-06 | 2020-01-16 | 株式会社マザー＆チャイルド | Testosterone secretion enhancing composition for increasing testosterone secretion in women, as well as aroma treatment composition, bath additives for aroma treatment, aroma treatment food, and aroma treatment tool |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2384111A1 (en) * | 2008-12-30 | 2011-11-09 | Basf Se | Pheromone dispenser |
-
2013
- 2013-08-10 JP JP2013167198A patent/JP5923469B2/en active Active
-
2014
- 2014-07-14 WO PCT/JP2014/068676 patent/WO2015022831A1/en active Application Filing
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2017016376A (en) | Piperidine derivative and preparation method and pharmaceutical use thereof. | |
| SG10201810985XA (en) | Tofacitinib oral sustained release dosage forms | |
| NZ712350A (en) | Abiraterone acetate formulation | |
| CA2917096C (en) | Sulfoximine substituted 5-fluoro-n-(pyridin-2-yl)pyridin-2-amine derivatives and their use as cdk9 kinase inhibitors | |
| MX2017003923A (en) | Use of isomerically pure or highly isomer-enriched cis- or trans-(2-isobutyl-4-methyl-tetrahydropyran-4-yl)acetate. | |
| MX2015012435A (en) | Substituted 3-phenylpropylamine derivatives for the treatment of ophthalmic diseases and disorders. | |
| MD20170048A2 (en) | Abiraterone acetate formulation and methods of use | |
| PH12015501096A1 (en) | Composition for immediate and extended release | |
| PH12017500810A1 (en) | Substituted 2,4 diamino-quinoline as new anticancer agents | |
| MX2016005668A (en) | Crystalline forms of therapeutic compounds and uses thereof. | |
| MX2015012111A (en) | Ship1 modulators and methods related thereto. | |
| NZ710291A (en) | 2-substituted-6-biarylmethylamino-9-cyclopentyl-9h-purine derivatives, use thereof as medicaments, and pharmaceutical compositions | |
| WO2015092810A3 (en) | Amorphous form of idelalisib | |
| MX2016001422A (en) | Pharmaceutical compositions of fingolimod. | |
| MX2016001138A (en) | Tricyclic benzoxaborole compound, preparation method therefor, and use thereof. | |
| UA117154C2 (en) | S1p3 antagonists | |
| MD20150053A2 (en) | Co-micronisation product comprising ulipristal acetate | |
| MX2017009289A (en) | Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the same. | |
| MX2015008733A (en) | 1,2,3-triazole-4-amine derivatives for the treatment of sigma receptor related diseases and disorders. | |
| MX2021006070A (en) | Ocular formulations for drug-delivery and protection of the anterior segment of the eye. | |
| MX2016004909A (en) | Composition containing eugenol as active ingredient for preventing or treating atopic dermatitis. | |
| IN2013MU01177A (en) | ||
| MX2015004312A (en) | Flavor and fragrance formulation (i). | |
| MX359955B (en) | Flavor and fragrance formulation (iii). | |
| JP2015036368A5 (en) |